Loading chat...
NY A03426
Bill
Status
1/27/2025
Primary Sponsor
John McDonald
Click for details
AI Summary
-
Establishes the "Collaborative Practice Medication Adherence Act" allowing licensed physicians to voluntarily enter into written protocols with qualified pharmacists to manage drug therapy for patients with chronic diseases
-
Defines "qualified pharmacist" as one with an unrestricted license, minimum two years of patient care experience within the last five years, and demonstrated competency in medication adherence through accredited programs
-
Permits qualified pharmacists under a protocol to adjust drug strength, frequency, or route of administration; order disease-related laboratory tests; perform routine patient monitoring including vital signs; and access patient medical records
-
Requires voluntary written consent from patients to participate in collaborative medication adherence services, with the right to discontinue at any time
-
Makes permanent the provisions of a 2011 law authorizing pharmacists to perform collaborative drug therapy management with physicians, removing the July 1, 2026 expiration date
Legislative Description
Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients; makes permanent certain provisions relating to authorizing pharmacists to perform with physicians in certain settings.
Last Action
referred to higher education
1/7/2026